Skip to main content
. 2019 Jul 29;6(3):80. doi: 10.3390/medicines6030080

Figure 2.

Figure 2

Small molecule FGF ligands and rationally designed oligosaccharides. (A) Early investigated polysulfated small molecule drugs with anti-angiogenic activity. (B) Structurally defined heparin-like dodecasaccharide generated through a completely synthetic process. Structure redrawn from ref. [55].